» Articles » PMID: 10229109

Correlation Analysis Between Frequencies of Circulating Antigen-specific IgG-bearing Memory B Cells and Serum Titers of Antigen-specific IgG

Overview
Journal Eur J Immunol
Date 1999 May 6
PMID 10229109
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies in mice have indicated that the long-lasting specific antibody responses seen after vaccination are probably due to the existence of long-lived plasma cells. Therefore, because the maintenance of humoral immunity does not necessarily reflect continuous restimulation of long-lived memory B cells, the question arises as to what degree antibody immunity, as determined by measuring serum immunoglobulin titers against a particular antigen, and memory B cell immunity, as determined by counting circulating memory B cells with specificity for that same antigen, correlate. Here, using a new assay combining two-step immunomagnetic enrichment with multiparameter flow cytometry to detect, enumerate and characterize antigen-specific memory B cells, we show for tetanus toxin C-fragment in blood of normal tetanus toxoid vaccinized donors, and for wasp venom phospholipase A1B in blood of wasp venom-allergic donors undergoing an immune therapy with wasp venom, that there is no statistically significant linear correlation between the frequencies of circulating antigen-specific IgG-bearing memory B cells and the serum titers of antigen-specific IgG. This lack of a statistically significant linear correlation is in accordance with the idea that B memory cells and plasma cells represent independently controlled forms of immunological memory.

Citing Articles

Differences in phenotype between long-lived memory B cells against Plasmodium falciparum merozoite antigens and variant surface antigens.

Reyes R, Turner L, Ssewanyana I, Jagannathan P, Feeney M, Lavstsen T PLoS Pathog. 2024; 20(10):e1012661.

PMID: 39466842 PMC: 11542837. DOI: 10.1371/journal.ppat.1012661.


Measurement of the Memory B Cell Response via Antibodies from Activated Cells.

Rockstroh C, Hintz K, Kannenberg J, Jassoy C Antibodies (Basel). 2024; 13(4).

PMID: 39449323 PMC: 11503279. DOI: 10.3390/antib13040081.


A multivalent mRNA-LNP vaccine protects against infection.

Alameh M, Semon A, Bayard N, Pan Y, Dwivedi G, Knox J Science. 2024; 386(6717):69-75.

PMID: 39361752 PMC: 11719173. DOI: 10.1126/science.adn4955.


CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells.

Schreiber S, Dressler L, Loffredo-Verde E, Asen T, Farber S, Wang W Front Immunol. 2024; 15:1340619.

PMID: 38711498 PMC: 11072186. DOI: 10.3389/fimmu.2024.1340619.


A method for rapid nanobody screening with no bias of the library diversity.

Tao Z, Zhao X, Wang H, Zhang J, Jiang G, Yu B iScience. 2024; 27(2):108966.

PMID: 38327779 PMC: 10847680. DOI: 10.1016/j.isci.2024.108966.